TIM S.A. projects 5%-6% revenue growth for 2025 with margin expansion focus
Q4 2024. Management View. CEO Alberto Griselli emphasized a strong year-end performance, with service revenue growing 6.4% in 2024, re ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...